Feline Primary Hyperparathyroidism

Feline primary hyperparathyroidism (PHPT) is an endocrine disorder characterized by the autonomous, excessive secretion of parathyroid hormone (PTH) from one or more abnormal parathyroid glands, resulting in persistent hypercalcemia [1]. Unlike secondary forms of hyperparathyroidism—which arise as compensatory responses to hypocalcemia from nutritional deficiencies or chronic kidney disease—PHPT is driven by intrinsic parathyroid gland pathology, most commonly a benign adenoma [1][6]. Although historically considered uncommon in cats, accumulating clinical evidence suggests the condition is more prevalent than previously recognized, and it remains an important differential diagnosis in any cat presenting with ionized hypercalcemia [1][3]. Excess PTH leads to excessive mobilization of calcium from bone, increased renal tubular calcium reabsorption, and enhanced intestinal calcium absorption, collectively producing the characteristic hypercalcemic state and its associated multi-systemic consequences [1][4].

Primary Cause: The vast majority of feline PHPT cases arise from a single, functional parathyroid adenoma—a benign, autonomously secreting neoplasm of one parathyroid gland [1][6]. Less frequently, the condition results from parathyroid adenocarcinoma (parathyroid carcinoma), which carries a more guarded prognosis [1][2]. Parathyroid hyperplasia involving multiple glands is recognized but appears less common in cats than in dogs [1]. A rare case of cystic parathyroid adenoma has also been documented in a cat, demonstrating that atypical presentations occur [8]. One case report has described the development of PHPT following radioiodine (¹³¹I) therapy for feline hyperthyroidism, raising the possibility that prior thyroid irradiation may be an incidental or causative factor in select cases [7].

Pathophysiological Mechanism: Normally, PTH secretion is tightly regulated by ionized calcium (iCa²⁺) concentrations via calcium-sensing receptors (CaSR) on parathyroid chief cells—rising iCa²⁺ suppresses PTH release, and falling iCa²⁺ stimulates it [1][4]. In PHPT, neoplastic or hyperplastic parathyroid cells lose normal feedback sensitivity; PTH is secreted autonomously and at inappropriately elevated levels regardless of calcium status [1]. The consequences of excess PTH are threefold:

1. ·Skeletal: PTH activates osteoclast-mediated bone resorption, releasing calcium and phosphate into circulation. Chronic stimulation can lead to generalized osteopenia and fibrous osteodystrophy [1][2].
2. ·Renal: PTH increases renal tubular reabsorption of calcium while simultaneously promoting phosphate excretion (phosphaturia), which lowers serum phosphorus. PTH also stimulates renal 1α-hydroxylase, increasing production of 1,25-dihydroxyvitamin D (calcitriol) [1][4].
3. ·Intestinal: Calcitriol enhances intestinal absorption of calcium and phosphorus, further amplifying hypercalcemia [1][4].

The resulting persistent hypercalcemia damages renal tubules (nephrocalcinosis), reduces renal concentrating ability, and may ultimately lead to chronic kidney disease if untreated [1][3][5]. Hypercalciuria also promotes calcium oxalate crystal and stone formation in the urinary tract [5].

A systematic diagnostic approach is essential, as PHPT must be distinguished from the more common causes of feline hypercalcemia—including idiopathic hypercalcemia, chronic kidney disease, neoplasia, and vitamin D toxicity [3][4].

Serum Biochemistry and Ionized Calcium:

• ·Total serum calcium: Elevated; however, total calcium can be falsely affected by protein binding and hydration status [4][5]
• ·Ionized calcium (iCa²⁺): The definitive measure of biologically active calcium; should be measured in all cases to confirm true hypercalcemia. iCa²⁺ measurement is more sensitive and specific than total calcium [4][5]
• ·Serum phosphorus: Typically low or low-normal due to PTH-mediated phosphaturia—a key differentiating feature from renal secondary hyperparathyroidism, where phosphorus is usually elevated [1][4]
• ·Blood urea nitrogen (BUN) and creatinine (CREA): May be elevated if hypercalcemia-induced nephropathy has developed; elevated CREA indicates concurrent or resultant renal dysfunction [1][4]
• ·Serum albumin (ALB): Should be assessed as a correction factor for total calcium; typically normal in PHPT [4]
• ·Alanine aminotransferase (ALT): Generally within normal limits; not a primary diagnostic marker but part of a complete metabolic panel [2]
• ·Alkaline phosphatase (ALP): May be mildly elevated due to increased osteoclastic bone resorption [1][2]
• ·Hematocrit (HCT): Generally unremarkable; mild normocytic normochromic anemia may occur in chronic disease [2]
• ·Urine specific gravity (USG): Often low (isosthenuria or hyposthenuria), reflecting renal concentrating defect from hypercalcemia [1][2]

Parathyroid Hormone Assay: Measurement of serum intact PTH (iPTH) is critical. In PHPT, PTH is inappropriately elevated or within the high-normal range in the presence of documented hypercalcemia [1][4]. Because calcium should suppress PTH in a normally regulated system, a detectable or elevated PTH concurrent with hypercalcemia is considered diagnostic of autonomous parathyroid secretion [1][6].

Imaging:

• ·Cervical ultrasonography: The modality of choice for localizing abnormal parathyroid tissue. Parathyroid adenomas typically appear as hypoechoic, well-defined nodules adjacent to or within the thyroid gland. Masses >4–5 mm are generally detectable by experienced sonographers [1][6][8]
• ·Radiography: Skeletal radiographs may reveal decreased bone density or subperiosteal bone resorption in chronic cases. Thoracic and abdominal radiographs help rule out neoplasia as a cause of hypercalcemia [7][1]
• ·MRI/CT: Advanced cross-sectional imaging may be used in complex cases or to characterize large or atypical cervical masses prior to surgery [7]

Cytology and Histopathology:

• ·Fine-needle aspirate cytology of a cervical mass may provide preliminary evidence of parathyroid origin [7]
• ·Definitive diagnosis relies on histopathological evaluation of the excised parathyroid gland, distinguishing adenoma, hyperplasia, or carcinoma [1][6][8]
• ·PTH concentration measured in cyst fluid (in cystic lesions) may markedly exceed plasma PTH, supporting a diagnosis of cystic parathyroid adenoma [8]

Surgical Parathyroidectomy (Treatment of Choice): Surgical excision of the affected parathyroid gland(s) is the definitive treatment for feline PHPT and is associated with an excellent outcome in most cases [1][6]. Intraoperative inspection of all four parathyroid glands is recommended; only visibly abnormal glands are removed to preserve residual parathyroid function [6]. Preoperative cervical ultrasound greatly aids surgical planning and localization of the adenoma [1][6].

Minimally Invasive Alternatives:

• ·Ultrasound-guided chemical ablation: Percutaneous ethanol or heat ablation of parathyroid adenomas has been described in cats and dogs as an alternative to surgery, particularly in patients who are poor anesthetic risks [1][6]. However, published data on long-term efficacy and complication rates in cats remain limited [1][6].

Medical Management of Hypercalcemia (Preoperative or Short-term):

• ·Intravenous saline (0.9% NaCl): Promotes calciuresis and reduces serum calcium; appropriate for hospitalized patients with severe hypercalcemia pending surgery [4]
• ·Bisphosphonates (e.g., pamidronate): Inhibit osteoclast-mediated bone resorption and reduce calcium levels; may be used as bridging therapy or in non-surgical candidates [4]
• ·Glucocorticoids: Not routinely indicated in PHPT (they are more applicable to lymphoma-associated or idiopathic hypercalcemia), but may be used in refractory situations [3][4]
• ·Dietary phosphorus restriction: May reduce compensatory calcitriol production; adjunctive in medical management [1]

Postoperative Management — Critical: Hypocalcemia: The most significant and predictable postoperative complication is hypocalcemia, arising from atrophy of the remaining normal parathyroid glands that were chronically suppressed by the prolonged hypercalcemic state [1][6]. This may occur within 12–72 hours postoperatively and can be life-threatening if severe.

• ·Monitoring of serum ionized calcium q8–12 hours postoperatively is essential [1][6]
• ·Oral calcium supplementation (calcium carbonate or calcium gluconate): Initiated prophylactically or at first signs of hypocalcemia [1][6]
• ·Vitamin D supplementation (calcitriol or dihydrotachysterol): Accelerates intestinal calcium absorption during the period of remaining parathyroid gland recovery; typically required for weeks to months postoperatively [1][6]
• ·IV calcium gluconate: Reserved for acute, severe hypocalcemia with tetany, seizures, or severe neuromuscular signs; must be administered slowly under continuous cardiac monitoring [6]

The overall prognosis for cats with PHPT treated with surgical parathyroidectomy is excellent, provided the lesion is benign (adenoma) and renal function is not severely compromised at the time of diagnosis [1][6].

• ·Surgical removal of a parathyroid adenoma is curative in the majority of cases, with normalization of ionized calcium typically occurring within days to weeks of surgery [1][6][8]
• ·In one documented feline case, ionized calcium normalized within days following right parathyroidectomy for a cystic parathyroid adenoma [8]
• ·The main postoperative risk factor affecting survival is severe postoperative hypocalcemia, which is manageable when anticipated and treated promptly; if unrecognized and untreated, it can be fatal [6]
• ·Cats with concurrent hypercalcemia-induced chronic kidney disease (CKD) at the time of diagnosis carry a more guarded long-term prognosis, as renal damage from prolonged hypercalcemia may not be fully reversible following parathyroid surgery [1][4]
• ·PHPT attributable to parathyroid carcinoma is rare in cats, but malignant disease carries a worse prognosis due to risk of local invasion and metastasis [1][2]
• ·Idiopathic hypercalcemia remains the most common cause of hypercalcemia in cats overall, and differentiating it from PHPT is important because management strategies and prognoses differ significantly [3][5]

Note: The current veterinary literature does not provide specific population-level mortality statistics (e.g., case-fatality rates or long-term survival curves) for feline PHPT as a distinct cohort. The prognosis statements above are based on clinical outcome descriptions and expert consensus from the cited references [1][6][8].

There are currently no known preventive measures for primary hyperparathyroidism in cats, as the condition arises from spontaneous, typically benign neoplastic transformation of parathyroid tissue, the etiology of which is not fully understood [1][2].

• ·No vaccine exists for PHPT, and it is a non-contagious condition [1][6]
• ·Routine screening: Given that PHPT may be more prevalent than historically recognized, measurement of ionized calcium (rather than relying solely on total calcium) is advisable as part of routine health screening in older cats, allowing earlier detection before severe end-organ damage—particularly renal injury—occurs [1][5]
• ·Post-radioiodine monitoring: Given that at least one case of PHPT following ¹³¹I therapy has been reported [7], cats treated with radioiodine for hyperthyroidism may warrant periodic monitoring of calcium homeostasis during follow-up, although a definitive causal relationship has not been established
• ·Nutritional balance: While nutritional secondary hyperparathyroidism (distinct from PHPT) is preventable through appropriate dietary calcium and phosphorus balance, no dietary intervention is known to prevent primary parathyroid adenoma formation [1]
• ·Early veterinary evaluation of any palpable cervical mass or persistent hypercalcemia is recommended to allow timely diagnosis and treatment before irreversible complications develop [1][6][8]